Erlotinib doesn't hurt but doesn't help standard head-and-neck therapy

Adding erlotinib did not increase treatment toxicity in squamous cell carcinoma of the head and neck, but it also did not improve survival.

Combining chemotherapy and radiation improves survival for some with rare brain cancer


Long-term follow-up results from two clinical trials have confirmed substantially longer survival for certain patients with anaplastic oligodendrogliomas if they are treated with a combination of chemotherapy and radiation therapy instead of radiation alone.

FDA Update - July/August 2012

News about pertuzumab injection (Perjeta); ondansetron (Zofran); carfilzomib (Kyprolis); Therascreen KRAS RGQ PCR Kit; Prostate Health Index (phi); and Prepopik

"Inoperable" pancreatic cancer may be treatable after all

"Inoperable" pancreatic cancer may be treatable after all

Oncologists at M.D. Anderson Cancer Center found the key to screening for pancreatic cancer lies in the interpretation of preoperative CT scans.

Chemoradiotherapy prolongs life for older patients with lung cancer

Survival improved for elderly patients with non-small cell lung cancer who had combined chemotherapy and radiotherapy rather than radiotherapy alone.

Fewer cycles of higher-dose chemotherapy best in advanced Hodgkin lymphoma

Six cycles of higher-dose chemotherapy, not the standard eight cycles or a lower-dose variant, should be the treatment of choice for advanced Hodgkin.

No link between BMI and surgical outcome in esophageal cancer

BMI appears to have no bearing on surgical complications or survival after esophagectomy following neoadjuvant chemoradiotherapy for adenocarcinoma.

Membrane temperature offers clue to oral mucositis risk in head and neck cancer


Thermal imaging can detect early changes in the temperature of mucosal surfaces that may signal mucositis in persons with head and neck cancer who are receiving chemoradiotherapy.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs